Objectives: Drug-eluting stent (DES) strut fracture (SF) is associated with higher incidence of Instent restenosis (ISR)-return of blockage in a diseased artery post stenting-than seen with bare metal stents (BMS). We hypothesize that concomitance of drug and SF leads to greater neointimal response.
| INTRODUCTION
In the United States alone, an estimated 92 million adults (more than 1 in 3) suffer from a form of cardiovascular disease (CVD)-with coronary heart disease representing nearly half of all deaths attributed to CVD. 1 The advent of endovascular stenting has revolutionized the treatment of CVD and while immensely impactful the first generation bare metal stents (BMS) were hampered by issues of in-stentrestenosis (ISR), tissue growth over the stent and within the lumen that restricted flow. Some 40% of patients required re-intervention. 2 The development of drug-eluting stents (DES) significantly reduced adverse events by locally eluting high concentrations of antiproliferative drugs in the vicinity of the stent struts. 3 However, clinical reports of stent strut fracture (SF) in DES emerged soon after clinical introduction. [4] [5] [6] Individual case studies described asymptomatic patients with ISR at angiographic follow-up (typically performed after 6 months). Intravascular ultrasound (IVUS) imaging confirmed discontinuity in device integrity and presence of
SF. Associated clinical characteristics and implications of SF identified
at meta-analysis included longer stents, tortuous vessels, right coronary artery implantations, saphenous venous bypass graft implantations, balloon over-expansion, and overlapping stent configurations.
Of the eight included studies for analysis, the mean SF per patient was 4% and ISR increased in the presence of SF. 7 Nakazawa et al. 8 discovered that 29% of stents had a fracture at autopsy, and that 67% of patients with SF suffered an adverse events including in-stent-thrombosis (IST) or ISR. The higher detection rate of SF than reported in clinical observational studies was attributed to the use of a high contrast film-based radiography, which is higher resolution (~80 μm) than angiography (~300 μm) or IVUS (~200 μm).
When observed, such SF associated responses are typically reported for DES not BMS. In the present study, we hypothesize that the presence of drug and SF leads to greater neointimal tissue formation, as a precursor to ISR. This hypothesis was tested in a preclinical model of iliac artery atherosclerosis, providing a level of translation that is not possible with bench-top experimental and computational models. 
| MATERIALS AND METHODS

| Animal systems
| Total plasma cholesterol
Blood samples were collected from a peripheral vessel at 21 days prior to implant (HF/HC diet initiation), day 0 (stent implantation), and 21 (prior to necropsy; see Figure 1 ). These samples were collected to monitor and assess the animal's health during the study and prior to euthanization. Animal body weights, with a body condition score, were recorded at days 0, 7, 14, and 21.
| Stent harvest and preparation
Animal were euthanized 21 days after stent implantation via an IV overdose of euthanasia solution in accordance with American Veterinary Medical Association guidelines. 11 Stented arteries were harvested for histopathological examination. Each artery was perfused at~100 mmHg with a physiologic solution followed by 10% Neutral Buffer Formaldehyde (NBF). The stented arteries were removed en bloc and placed in 10% NBF filled containers to ensure vessel integrity prior to processing, embedding, sectioning, and histopathologic analysis.
| Radiography and MicroCT
Two approximately perpendicular radiographs were taken to docu- 
| Light microscopy and histomorphometry
Resin embedded specimens were sectioned transversely in three regions. For intact stents, transverse sections were obtained from the proximal, mid, and distal regions. For prefractured stents, transverse sections of the stented vessel portion were obtained from the proximal, mid, and distal region targeting areas stent SF, as previously determined by micro-CT. All vessel sections were stained by hematoxylin-eosin and Verhoeff's tissue elastin stain.
Quantitative histomorphometric analysis was performed on each stented artery. Histological sections were measured using computerassist software (Olympus cellSens Dimension Desktop, v1; Olympus, Hamburg, Germany). Area measurements included the neointima, internal elastic lamina bounds, stent, and artery to external elastic lamina bounds. Stented segments were also histomorphologically scored for parameters such as injury, inflammation, endothelialization, neointimal fibrin deposition, and adventitial fibrosis. 
| Statistical analysis
All histological data scores were reported as the group mean AE SD.
Data sets were assessed for normality and variance equivalence.
When these conditions were met a t-test was conducted; otherwise a Mann-Whitney rank sum test was conducted. A P < 0.05 was considered statistically significant. All statistics were calculated with SigmaPlot version 11 (Systat Software Inc.; San Jose, CA) software.
3 | RESULTS
| Animal condition and cholesterol levels
At the conclusion of the study, 39 stents (n = 13 each of fractured EES and intact EES, n = 7 of fractured pre-eluted stents and n = 6 of intact pre-eluted stents) were successfully harvested from 20 animals that appeared to be in good health. One animal intended for study was excluded prior to stent placement because of evident aortic thrombus and one fractured pre-eluted stent was stripped from the delivery system in the introducer sheath and could not be implanted.
Animals on standard chow had clear serum and cholesterol levels within normal range-mean levels of circulating cholesterol at baseline were 51 AE 24 mg/dL, at implant were 32 AE 7 mg/dL and at prenecropsy were 27 AE 13 mg/dL. Animals on the HFHC diet (n = 13) had elevated levels of serum at the time of implant and before necropsy.
The HFHC groups' serums appeared cloudy/fatty, confirming hyperlipidemia. In the HFHC group, the mean levels of circulating cholesterol at baseline (prior to HFHC diet initiation) were 45 AE 21 mg/dL, at implant rose 25-fold to 1,155 AE 374 mg/dL and at prenecropsy even further to 1553 AE 325 mg/dL.
| MicroCT and radiography
All prefracture locations in the fractured specimen groups were identified during 3D reconstruction of microCT DICOM images (see 
| Morphometric and histological evaluation
Following intact EES implantation when animals were maintained on a HF/HC diet (comparing groups 2 and 6 - Table 1 In all groups, injury was minimal, endothelialization was complete or nearly complete, neointima was mature and consisted of organized smooth muscle cells, and adventitial fibrosis was absent There are distinct advantages and disadvantages of animal models in examining interventional procedures. 14 Arterial repair follows a similar coordinated sequence of biological events involved in vascular healing in both man and animal, although more rapidly and more repeatably in the latter. 15 The rabbit iliofemoral model exhibits less of an inflammatory foreign body reaction and slower rates of endothelial strut coverage (compared to the swine coronary model often selected in stent safety studies), although the latter process is still accelerated relative to human response. 16 The 21 day duration was determined to be suitable as a similar study demonstrated nearly 100% endothelialization at 21 days with similar devices. 17 In addition, the acceleration of an atherosclerotic disease state on HF diet and the size of the iliac artery being similar to human coronary arteries made this an attractive model system. Given the reproducibility of the rabbit 14,18-20 and lack of a reliable atherosclerotic porcine model, 21 despite the potential disadvantages, the selection of this iliofemoral model was deemed appropriate.
In terms of justification for the choice of pre-eluted EES as a pseudo BMS, it has been shown that angiographic and histological results in a porcine coronary model that polymer-coated stents were equivalent to the bare-metal version of device at 28, 90, and 180 day timepoints. 22 In addition, any inflammation (negligible to mild) with polymer-coated devices paralleled that of the bare-metal equivalent in this study.
It should also be noted that study findings were enhanced by advanced technical processes. To ensure that each fracture site was successfully cut, microCT of the explanted stented vessels was performed (see Figure 3) . The verification of fracture at each of the six pre-fracture sites per device ensured that the observed results could be directly linked to presence of stent SF. The representative histological images (Figure 4) illustrate what is confirmed with histomorphometric measurements (Table 1 and Figure 5) ; that there is greater neointimal tissue formation in the presence of fracture compared to intact devices when drug is present, both in healthy and diseased animals. As a result of neointimal tissue growth, lumen area to artery area ratio is also significantly reduced in the presence of SF.
Placing these results in context, Perkins et al. 22 evaluated the everolimus-release profile of the Xience EES in a porcine coronary artery model and found that after 28 days~71% of everolimus was released from the device and that everolimus concentration in the stented arterial vessel was 0.8 ng/mg at this timepoint. Relating these results to our 21 day study leads to the conclusion that everolimus is still expected to be present in the device and surrounding iliac tissue.
Based on our data, showing the increased neointimal hyperplasia response in EES with SF present, there is a detrimental effect of the therapeutic agent when fracture is present.
This leads to the concern that SF while drug is present (95% of everolimus is released at 4 months This study points to the need for rigorous examination of patients at follow-up for evidence of device discontinuity or SF, particularly in the case of DES implants. Often occurring at sites of inconsistent motion such as "hingepoints" this can be a difficult to detect through angiographic means alone. When predisposing factors are present, as reviewed in Chakravarty et al. 7 , such as longer stents, vessel tortuosity, right coronary artery location, overlapping configurations, and devices over-expanded at implant, the examination at follow-up should be potentially be at an earlier timepoint, while drug elution is likely still occurring, and examination needs to be even more considerate. Though patients may present as asymptomatic the evidence in this study suggests they are at a potentially greater risk of ISR and merit particular attention and observation. 
| Summary and perspective
